Americans for Pharma Reform

🚨 NO MORE PAYING 5X MORE THAN EUROPE FOR THE SAME DRUGS!

Pres. Trump is reining in Big Pharma & lowering the cost of prescription drugs by forcing Big Pharma to give America the same price as Europe.

Now Congress must follow his lead and take permanent action by codifying Trump's 'Most Favored Nation' policy into law!

A billion-dollar advertising machine helps protect billion-dollar drug prices. The podcast Big Pharma hopes you never find: https://bustbigpharmapodcast.com/Platforms

High drug prices are defended as the cost of innovation. The financial record complicates that claim. The podcast Big Pharma hopes you never find: https://bustbigpharmapodcast.com/Platforms

Big Pharma’s R&D excuse falls apart under peer-reviewed scrutiny. The argument survives because it protects profits. https://bustbigpharmapodcast.com/Platforms

If high drug prices are essential for innovation, patients deserve the receipts. Do you buy the industry’s argument?

https://bustbigpharmapodcast.com/Platforms

Pharmaceutical companies don't advertise their highest-margin drugs to inform you. They advertise them because the gap between manufacturing cost and price charged is large enough that every additional prescription an ad generates returns far more than the ad cost. You're not being educated — you're being recruited into a demand pool. The copay card makes the drug feel affordable while leaving the list price untouched. And the $9 billion spent on all of this in 2025 isn't a marketing expense. It's a price maintenance mechanism, legal, tax-deductible, and running largely unchallenged since 1997.

The podcast Big Pharma doesn't want you listening to — bustbigpharmapodcast.com/Platforms

AbbVie cut workers, cut research by 29%, gave the CEO a 75% raise, spent billions on advertising, and charged patients prices the innovation argument says exist to fund research the company was simultaneously defunding. When those are the facts, the innovation argument isn't a business case. It's a cover story — and the filings that prove it are public record sitting in plain sight.

The podcast Big Pharma doesn't want you listening to — bustbigpharmapodcast.com/Platforms

Every senator who asks why Americans pay more than anyone else in the world gets the same answer from the pharmaceutical industry: innovation. High prices fund the science. In 2025, they made $177 billion in profit, returned $97 billion to shareholders, and spent $5.9 billion less on research than the year before. The innovation argument requires the money to flow toward research. The financial filings show it went to shareholders, executives, and advertisers instead. That's not an allegation — it's in the filings.

The podcast Big Pharma doesn't want you listening to — bustbigpharmapodcast.com/Platforms